Walgreens Boots Alliance(US:WBA) Prnewswire·2025-03-31 09:45Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Walgreens Boots Alliance, Inc. regarding a class action lawsuit due to alleged misleading statements and regulatory violations during the specified class period [1][2]. Summary by Sections Allegations - The complaint alleges that Walgreens engaged in widespread violations of federal law related to prescription medication dispensation and reimbursement, contrary to its claims of improved regulatory compliance [1]. - It is claimed that the company's conduct would lead to increased regulatory scrutiny, civil liability, and reputational damage [1]. - The revenues from prescription medication sales are described as unsustainable due to their association with unlawful practices [1]. - Consequently, Walgreens' public statements are asserted to have been materially false and misleading throughout the relevant period [1]. Class Action Details - The class period for the lawsuit is defined as April 2, 2020, to January 16, 2025 [1]. - Shareholders are encouraged to register for the class action by the deadline of March 31, 2025, to potentially be appointed as lead plaintiffs [2]. - Registered shareholders will receive updates through a portfolio monitoring system regarding the case's progress [2]. Law Firm Background - The Gross Law Firm is recognized nationally for its class action work, focusing on protecting investors from deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflate stock prices [3].